229 filings
Page 4 of 12
8-K
cxc8klt 5yl3atkwczn
28 Feb 19
Results of Operations and Financial Condition
4:46pm
8-K
zk2b0gmuvrm6d
1 Feb 19
Departure of Directors or Certain Officers
5:25pm
8-K
0lz7ubppofgfy00gk8w8
23 Jan 19
Entry into a Material Definitive Agreement
7:35am
8-K
l596hsxg
7 Jan 19
Rigel Pharmaceuticals Provides Business Update
4:16pm
8-K
5johd3z931 g8xo
6 Nov 18
Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update
4:11pm
8-K
9y5uatsz
29 Oct 18
Entry into a Material Definitive Agreement
8:10am
8-K
5u9vk2
4 Oct 18
Regulation FD Disclosure
9:00am
8-K
3qhbk dl735v36
8 Aug 18
Rigel Announces Second Quarter 2018 Financial Results and Provides Company Update
4:34pm
8-K
4vti0
31 May 18
Departure of Directors or Certain Officers
5:10pm
8-K
50dp2o
18 May 18
Departure of Directors or Certain Officers
4:31pm
8-K
59aaeat02866k
1 May 18
Rigel Announces First Quarter 2018 Financial Results and Provides Company Update
4:50pm
8-K
ck5z62f5k
20 Apr 18
Results of Operations and Financial Condition
12:00am
8-K
9tp3ci h7r8ev
6 Mar 18
Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update
12:00am
8-K
tiyrp8a50imz2xwj
2 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
codzlxmysmcjf903x
26 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
9ezw8i
4 Jan 18
Rigel to Provide Business Review and Updated Phase 2 Results for Fostamatinib in AIHA
12:00am
8-K
8i0bf487q14lk
15 Dec 17
Rigel Announces Departure of Chief Financial Officer
12:00am
8-K
ixvi5w1jdn 29p
7 Nov 17
Rigel Announces Third Quarter 2017 Financial Results and Provides Company Update
12:00am
8-K
hovjw93g25
3 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
wt0y aj9nh7vr1tt
5 Oct 17
Termination of a Material Definitive Agreement
12:00am